Such targeting and ease of identification of cancer cells could allow oncologists to spot even tiny
numbers of diseased cells in a biopsy sample.
Not exact matches
A stronger immune system: Another study found that taking daily cold showers increases the
number of disease - fighting white blood
cells.
Those chemicals damage
cells, promote widespread internal (and invisible) inflammation, and lead to a vast
number of health concerns now considered common such as cardiovascular
disease and cancer.
Eggplant is loaded with phytonutrients that act as antioxidants that help to reduce the
number of free radicals in the body which damage
cells and may contribute to certain
diseases, including some cancers and heart
diseases.
Breastfeeding is contraindicated in infants with classic galactosemia (galactose 1 - phosphate uridyltransferase deficiency) 103; mothers who have active untreated tuberculosis
disease or are human T -
cell lymphotropic virus type I — or II — positive104, 105; mothers who are receiving diagnostic or therapeutic radioactive isotopes or have had exposure to radioactive materials (for as long as there is radioactivity in the milk) 106 — 108; mothers who are receiving antimetabolites or chemotherapeutic agents or a small
number of other medications until they clear the milk109, 110; mothers who are using drugs
of abuse («street drugs»); and mothers who have herpes simplex lesions on a breast (infant may feed from other breast if clear
of lesions).
«If we want to treat the greatest
number of diseases, we need to figure out how to get these molecules inside the
cells of patients — not just increasing the
number of target
cells but also hitting tissues other than the liver,» says Anderson, who co-founded a company called CRISPR Therapeutics to pursue those goals.
Because they can differentiate into almost any
cell type in the body, stem
cells have the potential to be used to create healthy
cells to treat a
number of diseases.
Today in
Cell and associated journals, 24 research studies from the landmark BLUEPRINT project and IHEC consortia reveal how variation in blood
cells» characteristics and
numbers can affect a person's risk
of developing complex
diseases such as heart
disease, and autoimmune
diseases including rheumatoid arthritis, asthma, celiac
disease and type 1 diabetes.
«A biological approach to precision medicine targets endless
number of diseases: Self - assembling platform effectively delivers inhibitory RNA molecules to targeted
cell populations.»
If this environment is harmed by chemicals, such as through damage to gut
cells, it could impact the health
of the organisms and would lead to a
number of fish
diseases but this technique will enable us to increase the tests we can carry out and improve our understanding
of how to preserve gut health.»
During the active
disease stage
of JIA, these
cells expand, grow in
number, re-circulate through inflamed areas
of patients» body, and migrate to the connective tissue
of patients» joints.
Mice lacking certain sequences had abnormally low
numbers of brain
cells that have been implicated in the progression
of Alzheimer's
disease.
Normal
cells contain as many as 35
of these repeats, but sometimes mutation pushes the
number of repeats beyond 50, which can lead to symptoms
of the
disease.
Mice without Del - 1 that had been induced to get EAE also had significantly higher
numbers of inflammatory
cells in their spinal cords at the
disease's peak, a fact that further experiments revealed was due to increased levels
of the signaling molecule IL - 17.
«In a large
number of diseases, ranging from cancer to ALS, major stress occurs in the affected
cells, leading the UPR pathway to be triggered,» he said.
Red blood
cell catechol - O - methyltransferase, histamine - N - methyltransferase, and a methanol - forming enzyme were examined in a
number of subjects with mental
diseases.
They also summarise the outcome
of clinical trials that have investigated the use
of mesenchymal stem
cells in the treatment
of a
number of inflammatory, degenerative and immune - mediated
diseases of cats.
On the flipside, targeting this growth factor or BCL - 2 could reduce NK
cell numbers and offer potential therapies for immune disorders such as some types
of autoimmune
diseases, sepsis or graft versus host
disease, a side effect
of bone marrow transplants.
The
number of extracted tumor
cells allows conclusions to be drawn with respect to the success
of therapy and the future course
of the
disease.
Kozai explains, «Dysfunction in glial
cells has been implicated as a cause and / or major contributor to an increasing
number of neurological and developmental
diseases.
But if homologous recombination could be worked out in human (embryonic) stem
cells, then cardiomyocytes with mutations in ion channels could be derived, as well as a large
number of other very useful
disease models
of other tissues.
The researchers focused on astrocytes after their initial finding that patients with Alzheimer's
disease have unusually high
numbers of adenosine receptors in these
cells.
A
number of new clinical trials aim to take
cells from a patient, such as blood
cells or immune
cells, edit them and transfer them back with new power to undermine
diseases like cancer or sickle
cell anemia.
In the future, medical researchers anticipate being able to use technologies derived from stem
cell research to treat cancer, spinal cord injuries, and muscle damage, amongst a
number of other
diseases and impairments.
Looking for immune abnormalities throughout the lifespan
of the mice, the group found that most immune system components stayed the same in
number, but a type
of brain - resident immune
cells called microglia that are known first responders to infection begin to divide and change early in the
disease.
Comparing the magnitude and characteristics
of WNV - specific CD4 + T
cell response in individuals
of similar ages with either neuroinvasive
disease or asymptomatic infection, the researchers found that, independent
of age, individuals with neuroinvasive
disease had higher
numbers of WNV - specific CD4 + T
cells.
Large
numbers of these pileups and double - strand breaks are lethal to the
cell, serving as a jumping off point for the development
of disease.
«The kidney is a very solid organ, which makes it very difficult to bring enough
number of cells upon transplantation,» explains Professor Kenji Osafune, whose lab at the Center for iPS
Cell Research and Application (CiRA) at Kyoto University, Japan, is using iPSCs to investigate new treatments for kidney
disease.
But if even a small
number of mutant mitochondria are retained after the transfer — a common occurrence — they can outcompete healthy mitochondria in a child's
cells and potentially cause the
disease the therapy was designed to avoid, experiments suggest.
His group showed that a small
number of stem -
cell like CD8 T
cells - called «memory»
cells - were enough to produce and repeatedly replenish all
of the T - effector
cells needed to fight the
disease.
A reduction in the
number of these
cells impairs vascular stability, and leads to cerebral small vessel
disease.
«Furthermore, this strategy may be beneficial for other pathological settings in which elevated
numbers of regulatory T
cells are desirable, such as autoimmune
diseases and solid organ transplantation,» Beilhack says.
International and regional organizations collect the
numbers of transplants annually by
disease, donor type, and stem
cell source from countries known to perform HSCT in World Health Organization (WHO) member states.
«Because Th17
cells have been linked to a
number of autoimmune
diseases, including multiple sclerosis, we thought our compound might inhibit Th17
cells in type 1 diabetes and possibly interfere with
disease progression,» said Solt.
The drug, called SelG1, also reduced the frequency
of pain crises in people with sickle
cell disease and reduced the
number of days they spent in the hospital.
The researchers counted the
numbers of a particular type
of immune
cell, known as microglia, in the samples and found that these were more numerous in the brains with Alzheimer's
disease.
The deck was stacked in favor
of success in the choice
of this particular
disease since it was known that the therapeutic gene just had to be expressed in a modest
number of blood
cells to achieve therapeutic benefit.
Research into Stem
Cells has grown exponentially over the past two decades and has already yielded successful or promising therapies for a
number of diseases.
Finkbeiner's team has already characterized a
number of these
cell lines for differences between people with the
disease and their unaffected family members.
«Since that time, Lorenz has made a significant
number of transformative contributions and developed protocols that have fundamentally changed the way we create stem
cells in the lab,» said Lennart Mucke, MD, director
of the Gladstone Institute
of Neurological
Disease.
Not so long ago, human embryonic stem
cell (hESC) research and SCNT were being hailed as the future
of regenerative medicine, capable
of generating cures and therapies for any
number of diseases and conditions.
They examined 17 cancer types in 69 countries and found a strong correlation between the
number of stem -
cell divisions and the incidence
of the
disease, regardless
of the countries» environment or state
of economic development.
The study was funded by Florida State University; the National Institute
of Allergy and Infectious
Disease (grant
numbers AI119530 and AI111250), the National Institute
of Neurological Disorders and Stroke (grant
numbers NS048271, NS095348, NS047344, NS051630 and NS079625); and the Maryland Stem
Cell Research Fund.
The massive
number of cells within the OSVZ
of humans «tells us we have to be careful when modeling human brain
diseases in mice,» says Kriegstein.
The findings have implications for the design
of cancer vaccines and what are called adoptive T
cell therapies; when T
cells are collected from a patient and grown in the laboratory, increasing in
number before they are given back to the patient to help the immune system fight
disease.
The question arises nearly every day and it is not surprising given the abundance
of articles and advertisements promoting the use
of «stem
cell treatments» for a staggering
number of diseases and injuries.
Stem
cell researchers from UCLA used a high resolution technique to examine the genome, or total DNA content,
of a pair
of human embryonic stem
cell lines and found that while both lines could form neurons, the lines had differences in the
numbers of certain genes that could control such things as individual traits and
disease susceptibility.
Adult stem
cell therapy has been shown in a
number of clinical trials to slow and, in some cases, even reverse heart deterioration in patients with coronary artery
disease (CAD).
Based on positive results produced from a
number of scientific clinical trials, coronary artery
disease therapy using adult stem
cells is a promising new method
of treatment for coronary artery
disease patients.
These findings will enable increasing
numbers of researchers across the world to use these stem -
cell like
cells to study
disease and explore potential regenerative therapies.